Feldman EL - Search Results

1

Priorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS.

Howard IM, Babu S, Carter C, Sakowski SA, Kurent JE, Cudkowicz ME, Feldman EL. Howard IM, et al. Among authors: feldman el. Ann Neurol. 2024 Dec;96(6):1035-1039. doi: 10.1002/ana.27097. Epub 2024 Oct 10. Ann Neurol. 2024. PMID: 39390661 Review.

2

Neuroinflammation, COX-2, and ALS--a dual role?

Consilvio C, Vincent AM, Feldman EL. Consilvio C, et al. Among authors: feldman el. Exp Neurol. 2004 May;187(1):1-10. doi: 10.1016/j.expneurol.2003.12.009. Exp Neurol. 2004. PMID: 15081582 Review.

3

Strategic approaches to developing drug treatments for ALS.

Vincent AM, Sakowski SA, Schuyler A, Feldman EL. Vincent AM, et al. Among authors: feldman el. Drug Discov Today. 2008 Jan;13(1-2):67-72. doi: 10.1016/j.drudis.2007.10.011. Epub 2007 Nov 26. Drug Discov Today. 2008. PMID: 18190866 Free PMC article. Review.

4

Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Sakowski SA, Schuyler AD, Feldman EL. Sakowski SA, et al. Among authors: feldman el. Amyotroph Lateral Scler. 2009 Apr;10(2):63-73. doi: 10.1080/17482960802160370. Amyotroph Lateral Scler. 2009. PMID: 18608100 Free PMC article. Review.

5

Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.

Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL. Lunn JS, et al. Among authors: feldman el. Dev Neurobiol. 2009 Nov;69(13):871-84. doi: 10.1002/dneu.20747. Dev Neurobiol. 2009. PMID: 19672955 Free PMC article.

6

Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression.

Sakowski SA, Heavener SB, Lunn JS, Fung K, Oh SS, Spratt SK, Hogikyan ND, Feldman EL. Sakowski SA, et al. Among authors: feldman el. Gene Ther. 2009 Nov;16(11):1292-9. doi: 10.1038/gt.2009.111. Epub 2009 Sep 3. Gene Ther. 2009. PMID: 19727131 Free PMC article.

7

Stem cell technology for the study and treatment of motor neuron diseases.

Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. Lunn JS, et al. Among authors: feldman el. Regen Med. 2011 Mar;6(2):201-13. doi: 10.2217/rme.11.6. Regen Med. 2011. PMID: 21391854 Free PMC article. Review.

8

Stem cell technology for neurodegenerative diseases.

Lunn JS, Sakowski SA, Hur J, Feldman EL. Lunn JS, et al. Among authors: feldman el. Ann Neurol. 2011 Sep;70(3):353-61. doi: 10.1002/ana.22487. Ann Neurol. 2011. PMID: 21905078 Free PMC article. Review.

9

Translational stem cell therapy for amyotrophic lateral sclerosis.

Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL. Boulis NM, et al. Among authors: feldman el. Nat Rev Neurol. 2011 Dec 13;8(3):172-6. doi: 10.1038/nrneurol.2011.191. Nat Rev Neurol. 2011. PMID: 22158518 Review.

10

Intraspinal transplantation of neurogenin-expressing stem cells generates spinal cord neural progenitors.

Lunn JS, Pacut C, Stern E, Sakowski SA, Velkey JM, O'Shea S, Feldman EL. Lunn JS, et al. Among authors: feldman el. Neurobiol Dis. 2012 Apr;46(1):59-68. doi: 10.1016/j.nbd.2011.12.044. Epub 2012 Jan 8. Neurobiol Dis. 2012. PMID: 22245661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters